ITMI910843A1 - Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice - Google Patents

Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice

Info

Publication number
ITMI910843A1
ITMI910843A1 IT000843A ITMI910843A ITMI910843A1 IT MI910843 A1 ITMI910843 A1 IT MI910843A1 IT 000843 A IT000843 A IT 000843A IT MI910843 A ITMI910843 A IT MI910843A IT MI910843 A1 ITMI910843 A1 IT MI910843A1
Authority
IT
Italy
Prior art keywords
dihydroergocriptine
containing alpha
neuroprotective action
medication containing
alpha
Prior art date
Application number
IT000843A
Other languages
English (en)
Inventor
Germano Coppi
Federico Mailland
Stefano Poli
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of ITMI910843A0 publication Critical patent/ITMI910843A0/it
Priority to ITMI910843A priority Critical patent/IT1245369B/it
Priority to DE69131521T priority patent/DE69131521T2/de
Priority to EP91116311A priority patent/EP0505608B1/en
Priority to ES91116311T priority patent/ES2052467T1/es
Priority to DK91116311T priority patent/DK0505608T3/da
Priority to AT91116311T priority patent/ATE183093T1/de
Priority to DE199191116311T priority patent/DE505608T1/de
Priority to JP3249414A priority patent/JPH04312590A/ja
Priority to CA002064112A priority patent/CA2064112C/en
Priority to KR1019920004973A priority patent/KR100196445B1/ko
Publication of ITMI910843A1 publication Critical patent/ITMI910843A1/it
Priority to GR920300126T priority patent/GR920300126T1/el
Application granted granted Critical
Publication of IT1245369B publication Critical patent/IT1245369B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ITMI910843A 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice IT1245369B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITMI910843A IT1245369B (it) 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
DE199191116311T DE505608T1 (de) 1991-03-28 1991-09-25 Alpha-ergocryptine enthaltende pharmazeutische zusammensetzungen mit nervenschuetzender wirkung.
EP91116311A EP0505608B1 (en) 1991-03-28 1991-09-25 Alpha-dihydroergocryptine pharmaceutical preparations with neuroprotective acitivity
ES91116311T ES2052467T1 (es) 1991-03-28 1991-09-25 Preparaciones farmaceuticas de alfa-dihidroergocriptina con actividad neuroprotectora.
DK91116311T DK0505608T3 (da) 1991-03-28 1991-09-25 Farmaceutiske alfa-dihydroergocryptinpræparater med neurobeskyttende virkning
AT91116311T ATE183093T1 (de) 1991-03-28 1991-09-25 Alpha-ergocryptine enthaltende pharmazeutische zusammensetzungen mit nervenschützender wirkung
DE69131521T DE69131521T2 (de) 1991-03-28 1991-09-25 Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung
JP3249414A JPH04312590A (ja) 1991-03-28 1991-09-27 神経防護性α−ジヒドロエルゴクリプチン医薬製剤
CA002064112A CA2064112C (en) 1991-03-28 1992-03-26 .alpha.-dihydroergocryptine pharmaceutical preparations with neuroprotective activity
KR1019920004973A KR100196445B1 (ko) 1991-03-28 1992-03-26 신경보호활성을 갖는 알파-디하이드로에르고크립틴 약제학적 제제
GR920300126T GR920300126T1 (it) 1991-03-28 1993-03-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910843A IT1245369B (it) 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice

Publications (3)

Publication Number Publication Date
ITMI910843A0 ITMI910843A0 (it) 1991-03-28
ITMI910843A1 true ITMI910843A1 (it) 1992-09-28
IT1245369B IT1245369B (it) 1994-09-20

Family

ID=11359300

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910843A IT1245369B (it) 1991-03-28 1991-03-28 Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice

Country Status (10)

Country Link
EP (1) EP0505608B1 (it)
JP (1) JPH04312590A (it)
KR (1) KR100196445B1 (it)
AT (1) ATE183093T1 (it)
CA (1) CA2064112C (it)
DE (2) DE505608T1 (it)
DK (1) DK0505608T3 (it)
ES (1) ES2052467T1 (it)
GR (1) GR920300126T1 (it)
IT (1) IT1245369B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041855A1 (it) * 2004-09-29 2004-12-29 Polichem Sa Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200603B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutiche ad attivita dopaminergica

Also Published As

Publication number Publication date
DE69131521T2 (de) 2000-03-30
CA2064112C (en) 2002-12-31
ATE183093T1 (de) 1999-08-15
KR920017652A (ko) 1992-10-21
EP0505608A3 (en) 1993-02-03
ES2052467T1 (es) 1994-07-16
DE505608T1 (de) 1993-03-18
JPH04312590A (ja) 1992-11-04
KR100196445B1 (ko) 1999-06-15
GR920300126T1 (it) 1993-03-16
EP0505608A2 (en) 1992-09-30
EP0505608B1 (en) 1999-08-11
DE69131521D1 (de) 1999-09-16
DK0505608T3 (da) 2000-03-20
ITMI910843A0 (it) 1991-03-28
IT1245369B (it) 1994-09-20
CA2064112A1 (en) 1992-09-29

Similar Documents

Publication Publication Date Title
ES2099735T3 (es) Jeringuilla de dosis multiple tipo pluma.
EP0552256A4 (it)
TW206916B (it)
ITFI910296A0 (it) Laringoscopio basculante a spatula ricurva motorizzata, particolarmente per praticare l' intubazione di pazienti sotto anestesia o rianimazione
DE69224941D1 (de) Arzneimittelabgabekatheter
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
ITMI911299A1 (it) Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
NO981911D0 (no) Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
SG86284A1 (en) Use of (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide for the manufacture of medicaments for the treatment of anxiety
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
EP0467564A3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
ITMI910843A1 (it) Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ITMI912652A0 (it) Medicamento ad attivita' antielasica
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.
EP0656208A3 (de) Verwendung von synthetischen Huminaten zur Herstellung eines Arzneimittels zur Behandlung von Schleimhauterkrankungen.
DK0495721T3 (da) Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax
IT1254632B (it) Uso di acido iodesossicolico come promotore di assorbimento di farmaci
ES1019006Y (es) Jeringa de anestesia dental desechable.
IT213228Z2 (it) Erogatore a soffietto di sostanze medicinali per microclisma, con cannula incorporata

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970326